{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T02:38:13Z","timestamp":1769827093604,"version":"3.49.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.bbr.2013.02.039","type":"journal-article","created":{"date-parts":[[2013,3,5]],"date-time":"2013-03-05T17:27:09Z","timestamp":1362504429000},"page":"24-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Effect of an mGlu2\/3 receptor antagonist on depressive behavior induced by withdrawal from chronic treatment with methamphetamine"],"prefix":"10.1016","volume":"246","author":[{"given":"Michihiko","family":"Iijima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Koike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeyuki","family":"Chaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2013.02.039_bib0005","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0165-6147(02)02086-2","article-title":"A \u2018crash\u2019 course on psychostimulant withdrawal as a model of depression","volume":"23","author":"Barr","year":"2002","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.bbr.2013.02.039_bib0010","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.neuropharm.2012.05.022","article-title":"mGlu2\/3 and mGlu5 receptors: potential targets for novel antidepressants","volume":"66","author":"Chaki","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2013.02.039_bib0015","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.neuropharm.2003.10.009","article-title":"MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity","volume":"46","author":"Chaki","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2013.02.039_bib0020","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0006-3223(02)01730-4","article-title":"Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents","volume":"54","author":"Cryan","year":"2003","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.bbr.2013.02.039_bib0025","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S0006-3223(99)00236-X","article-title":"Reciprocal changes in prefrontal and limbic dopamine responsiveness to aversive and rewarding stimuli after chronic mild stress: implications for the psychobiology of depression","volume":"46","author":"Di Chiara","year":"1999","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.bbr.2013.02.039_bib0030","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1017\/S1461145711001702","article-title":"Duman RS. mTOR activation is required for the antidepressant effects of mGluR2\/3 blockade","volume":"15","author":"Dwyer","year":"2012","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2013.02.039_bib0035","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.pnpbp.2009.11.018","article-title":"Elevated level of metabotropic glutamate receptor 2\/3 in the prefrontal cortex in major depression","volume":"34","author":"Feyissa","year":"2010","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.bbr.2013.02.039_bib0040","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s00213-003-1444-8","article-title":"Anxiolytic effects of a novel group II metabotropic glutamate receptor agonist (LY354740) in the fear-potentiated startle paradigm in humans","volume":"168","author":"Grillon","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2013.02.039_bib0045","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0022-3565(24)37253-2","article-title":"Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors","volume":"284","author":"Helton","year":"1998","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.bbr.2013.02.039_bib0050","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.neuint.2010.07.011","article-title":"AMPA receptor mediates mGlu 2\/3 receptor antagonist-induced dopamine release in the rat nucleus accumbens shell","volume":"57","author":"Karasawa","year":"2010","journal-title":"Neurochemistry International"},{"key":"10.1016\/j.bbr.2013.02.039_bib0055","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neulet.2005.09.058","article-title":"A metabotropic glutamate 2\/3 receptor antagonist, MGS0039, increases extracellular dopamine levels in the nucleus accumbens shell","volume":"393","author":"Karasawa","year":"2006","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.bbr.2013.02.039_bib0060","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1124\/jpet.103.052027","article-title":"Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)\/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats","volume":"306","author":"Kenny","year":"2003","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.bbr.2013.02.039_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0028-3908(97)00191-3","article-title":"LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors","volume":"37","author":"Kingston","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2013.02.039_bib0070","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.neuropharm.2011.08.034","article-title":"Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists","volume":"61","author":"Koike","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2013.02.039_bib0075","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.bcp.2007.05.020","article-title":"Metabotropic glutamate 2\/3 receptor activation induced reward deficits but did not aggravate brain reward deficits associated with spontaneous nicotine withdrawal in rats","volume":"74","author":"Liechti","year":"2007","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.bbr.2013.02.039_bib0080","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0091-3057(99)00213-0","article-title":"Time-dependent alterations in ICSS thresholds associated with repeated amphetamine administrations","volume":"65","author":"Lin","year":"2000","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.bbr.2013.02.039_bib0085","first-page":"17","article-title":"Postcocaine anhedonia. An animal model of cocaine withdrawal","volume":"4","author":"Markou","year":"1991","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2013.02.039_bib0090","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1111\/j.1460-9568.2007.05546.x","article-title":"Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell","volume":"25","author":"Paterson","year":"2007","journal-title":"European Journal of Neuroscience"},{"key":"10.1016\/j.bbr.2013.02.039_bib0095","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF02244248","article-title":"Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats","volume":"103","author":"Paulson","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2013.02.039_bib0100","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"1997"},{"key":"10.1016\/j.bbr.2013.02.039_bib0105","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/sj.npp.1301408","article-title":"Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression","volume":"33","author":"Schlaepfer","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2013.02.039_bib0110","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/1025389031000146773","article-title":"Potter WZ LY354740, an mGlu2\/3 receptor agonist as a novel approach to treat anxiety\/stress","volume":"6","author":"Schoepp","year":"2003","journal-title":"Stress"},{"key":"10.1016\/j.bbr.2013.02.039_bib0115","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2174\/157015906778520773","article-title":"Neurochemistry of the nucleus accumbens and its relevance to depression and antidepressant action in rodents","volume":"4","author":"Shirayama","year":"2006","journal-title":"Current Neuropharmacology"},{"key":"10.1016\/j.bbr.2013.02.039_bib0120","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/sj.bjp.0703923","article-title":"Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist","volume":"132","author":"Tatarczy\u0144ska","year":"2001","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.bbr.2013.02.039_bib0125","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/archpsyc.62.11.1228","article-title":"Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe","volume":"62","author":"Tremblay","year":"2005","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.bbr.2013.02.039_bib0130","first-page":"S166","article-title":"Further evidence for a metabotropic glutamate group II antagonist mechanism for the induction of antidepressant-like effects in rodents","volume":"31","author":"Witkin","year":"2006","journal-title":"Neuropsychopharmacology"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432813001216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432813001216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:02:53Z","timestamp":1759064573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432813001216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":26,"alternative-id":["S0166432813001216"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2013.02.039","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of an mGlu2\/3 receptor antagonist on depressive behavior induced by withdrawal from chronic treatment with methamphetamine","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2013.02.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}